Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of infliximab and ciclosporin in steroid-resistant ulcerative colitis
2008-001968-36Phase 3Completed
- Sponsor
- Swansea University
- Start
- Jul 2008
- Modality
- Small Molecules, Peptides, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in autoimmune colitis comparing Infliximab arm with Ciclosporin arm (2 arms). Primary endpoints: Need for surgery (e.g., colectomy), Disease activity and 2 more. Started Jul 2008; status: completed.
02
Drugs
infliximabcyclosporine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2008-001968-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001968-36.